Nurix Therapeutics welcomes Dr. Roger Dansey to its Board of Directors
– USA, CA – Nurix Therapeutics, Inc. (Nasdaq: NRIX), focused on the discovery, development, and commercialization of targeted protein degradation medicines in oncology and autoimmune diseases, announced the appointment of Dr.…